LCM
DCPH

Laurion Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Laurion Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-274,634
Closed -$4.32M – 794
2024
Q1 		$4.32M Buy
+274,634
New +$4.23M 0.04% 272
2022
Q3 		– Sell
-358,380
Closed -$4.71M – 633
2022
Q2 		$4.71M Sell
358,380
-100,910
-22% -$1.11M 0.07% 169
2022
Q1 		$4.26M Buy
+459,290
New +$3.91M 0.05% 169
2020
Q2 		– Sell
-81,500
Closed -$3.35M – 1237
2020
Q1 		$3.35M Buy
+81,500
New +$4.53M 0.04% 292
2018
Q4 		– Sell
-11,228
Closed -$435K – 1487
2018
Q3 		$435K Sell
11,228
-141,739
-93% -$5.24M ﹤0.01% 858
2018
Q2 		$6.02M Buy
+152,967
New +$4.5M 0.05% 314
2018
Q1 		– Sell
-217,800
Closed -$4.94M – 1775
2017
Q4 		$4.94M Sell
217,800
-7,200
-3% -$141K 0.03% 520
2017
Q3 		$4.27M Buy
+225,000
New +$4.12M 0.02% 555

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Laurion Capital Management's DCPH Position: Q2 2024 in Review

Laurion Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 274,634 shares — an estimated $4.32M sold.

Laurion Capital Management first reported a position in DCPH in Q3 2017 and held it in 8 quarters. The position peaked at $6.02M in Q2 2018. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Laurion Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Laurion Capital Management sold 274,634 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4.32M.
  • Laurion Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
  • Laurion Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $6.02M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Laurion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.